Emphysema

1,218,749views

Emphysema

D115

D115

Systemic lupus erythematosus
Turner syndrome
Klinefelter syndrome
Fragile X syndrome
Prader-Willi syndrome
Angelman syndrome
Endocrine system anatomy and physiology
Restrictive lung diseases
Down syndrome (Trisomy 21)
Pyloric stenosis
Innate immune system
Antibody classes
HIV (AIDS)
Myasthenia gravis
Meningitis
Multiple sclerosis
Guillain-Barre syndrome
Delirium
Dementia with Lewy bodies
Alzheimer disease
Seizures and epilepsy
Normal pressure hydrocephalus
Huntington disease
Parkinson disease
Concussion and traumatic brain injury
Lambert-Eaton myasthenic syndrome
Major depressive disorder
Generalized anxiety disorder
Schizophrenia
Spina bifida
Phenylketonuria (NORD)
Tay-Sachs disease (NORD)
Cerebral palsy
Hyperparathyroidism
Hypoparathyroidism
Diabetes insipidus
Graves disease
Diabetes mellitus
Cushing syndrome
Primary adrenal insufficiency
Breast cancer
Benign prostatic hyperplasia
Ovarian cyst
Pneumonia
Chronic bronchitis
Asthma
Emphysema
Pulmonary embolism
Pneumothorax
Pleural effusion
Bronchiectasis
Acute respiratory distress syndrome
Mycobacterium tuberculosis (Tuberculosis)
Cor pulmonale
Bacterial epiglottitis
Laryngomalacia
Respiratory syncytial virus
Cystic fibrosis
Sudden infant death syndrome
Disseminated intravascular coagulation
Sickle cell disease (NORD)
Chronic leukemia
Acute leukemia
Myocardial infarction
Deep vein thrombosis
Hypoplastic left heart syndrome
Angina pectoris
Aortic dissection
Aortic dissections and aneurysms: Pathology review
Iron deficiency anemia
Aplastic anemia
Autoimmune hemolytic anemia
Polycythemia vera (NORD)
Immune thrombocytopenia
Epstein-Barr virus (Infectious mononucleosis)
Non-Hodgkin lymphoma
Hodgkin lymphoma
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Beta-thalassemia
Alpha-thalassemia
Raynaud phenomenon
Arterial disease
Peripheral artery disease
Coronary artery disease: Pathology review
Pericarditis and pericardial effusion
Rheumatic heart disease
Heart failure
Patent ductus arteriosus
Ventricular septal defect
Pulmonary valve disease
Kawasaki disease
Tetralogy of Fallot
Urinary tract infections: Clinical
Kidney stones
Chronic kidney disease
Nephrotic syndromes: Pathology review
Acute pyelonephritis
Chronic pyelonephritis
Lower urinary tract infection
Neurogenic bladder
Bladder exstrophy
Hypospadias and epispadias
Polycystic kidney disease
Hemolytic-uremic syndrome
Nephroblastoma (Wilms tumor)
Vesicoureteral reflux
Renal failure: Pathology review
Gastrointestinal bleeding: Pathology review
Gastroesophageal reflux disease (GERD)
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Zollinger-Ellison syndrome
Wilson disease
Malabsorption syndromes: Pathology review
Ulcerative colitis
Crohn disease
Irritable bowel syndrome
Diverticulosis and diverticulitis
Appendicitis
Portal hypertension
Intussusception
Celiac disease
Gastric cancer
Acute pancreatitis
Chronic pancreatitis
Chronic cholecystitis
Acute cholecystitis
Gallstones
Jaundice
Viral hepatitis
Hepatitis A and Hepatitis E virus
Hepatitis B and Hepatitis D virus
Hepatitis C virus
Cirrhosis
Biliary atresia
Hirschsprung disease
Paget disease of bone
Osteoporosis
Osteoarthritis
Atopic dermatitis
Varicella zoster virus
Osteomalacia and rickets
Bone tumors
Rheumatoid arthritis
Ankylosing spondylitis
Gout
Fibromyalgia
Hypothyroidism
Hypomagnesemia
Glycogen storage disorders: Pathology review
Glycogen storage disease type II (NORD)
Myalgias and myositis: Pathology review
Polymyositis
Dermatomyositis
Lordosis, kyphosis, and scoliosis
Osgood-Schlatter disease (traction apophysitis)
Legg-Calve-Perthes disease
Muscular dystrophy
Scleroderma
Psoriasis
Lichen planus
Pemphigus vulgaris
Acne vulgaris
Erythema multiforme
Stevens-Johnson syndrome
Lyme Disease
Herpes simplex virus
Skin cancer
Human herpesvirus 8 (Kaposi sarcoma)
Rubella virus
Measles virus
Burns
Shock
Cri du chat syndrome
Prostate cancer
Post-traumatic stress disorder
Wiskott-Aldrich syndrome
Ataxia-telangiectasia
DiGeorge syndrome
Persistent truncus arteriosus
Membranoproliferative glomerulonephritis
Poststreptococcal glomerulonephritis
Menstrual cycle

Transcript

Watch video only

Emphysema means “inflate or swell”, which makes sense because in the lungs of people with emphysema, the alveolar air sacs, which are the thin walled air spaces at the ends of the airways where oxygen and carbon dioxide are exchanged, become damaged or destroyed.

The alveoli permanently enlarge and lose elasticity, and as a result, individuals with emphysema typically have difficulty with exhaling, which depends heavily on the ability of lungs to recoil like elastic bands.

Emphysema’s actually lumped under the umbrella of chronic obstructive pulmonary disease (or COPD), along with chronic bronchitis.

The two differ in that chronic bronchitis is defined by clinical features, like the productive cough, whereas emphysema is defined by structural changes, mainly enlargement of the air spaces.

That being said, they almost always coexist, probably because they share the same major cause—smoking.

With COPD, the airways become obstructed, the lungs don’t empty properly, and that leaves air trapped inside the lungs.

For that reason, the maximum amount of air people with COPD can breath out in a single breath, known as the FVC, or forced vital capacity, is lower.

This reduction is especially noticeable in the first second of air breathed out in a single breath, called FEV1forced expiratory volume (in one second), which typically is reduced even more than the FVC.

A useful metric therefore is the FEV1 to FVC ratio, which, since the FEV1 goes down even more than FVC, causes the FEV1 to FVC ratio to go down as well.

Alright so say normally your FVC is 5 L, and your FEV1 is 4 L, your FEV1 to FVC ratio would end up being 80%.

Now, someone with COPD’s FVC might be 4 L instead, which is lower than normal, but the volume of air that he or she can expire in the first second is only 2 L, so not only are both these values lower, but their ratio is lower as well—and this is a hallmark of COPD.

All that had to do with air breathed out right? Conversely, for air going in, the TLC, or total lung capacity, which is the maximum volume of air that can be taken in or inspired into the lungs, is actually often often higher because of the air trapping.

Alright, so emphysema is a form of COPD, that’s based on structural changes in the lung, specifically a destruction of the alveoli.

Normally, though oxygen flows out of the alveoli and into the blood while carbon dioxide makes the reverse commute, but when the lung tissue is exposed to irritants like cigarette smoke, it triggers an inflammatory reaction that upsets the delicate alveolar walls and affects the flow of gases.

Inflammatory reactions attract various immune cells which release inflammatory chemicals like leukotriene B4, IL-8, and TNF alpha, as well as proteases, like elastases and collagenases.

These proteases break down key structural proteins in the connective tissue layer like collagen, as well as elastin, which is a protein that gives the tissue elasticity, and this leads to the problems seen in emphysema.

In healthy lungs, during exhalation, air whizzes through the airways with high velocity, creating a low pressure environment in the airway.

This is due to the Bernoulli principle, where, as a fluid—which includes air—moves at higher velocity, it must have lower pressure. Now this lower pressure tends to pull the tiny airway inward.

Strong healthy airway walls full of elastin can withstand that pressure and don’t collapse; they hold the airway open and allow air to fully escape during exhalation.

With emphysema though, that elastin’s lost, which makes the airway walls weak and allow that low pressure system to pull the walls inward and collapse during exhalation.

This ultimately leads to air-trapping because the collapsed airway traps a tiny bit of air distal to the point of collapse.

Also, this loss of elastin makes the lungs more compliant, meaning that when air blows into them, they easily expand and then hold onto that air instead of expelling it during exhalation, and so the lungs start to look like large thin plastic bags.

The loss of elastin also leads to a breakdown of the thin alveolar walls called septa.

Without these walls, neighboring alveoli coalesce into larger and larger air spaces, which means the surface area available for gas exchange is reduced (relative to the expanding volume), which affects oxygen and carbon dioxide levels.

This process all happens in the acinus, which is the endings of the lung airways where those clusters of alveoli are located.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease" American Journal of Respiratory and Critical Care Medicine (2013)
  6. "Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology" European Respiratory Journal (2005)
  7. "Screening for Chronic Obstructive Pulmonary Disease" JAMA (2016)
  8. "Endocarditis" JAMA (2018)
  9. "Infective endocarditis" The Lancet (2016)
  10. "Endocardite infectieuse. Épidémiologie, physiopathologie et anatomopathologie" La Presse Médicale (2019)